IL285536A - A selective inhibitor of protein arginine methyltransferase 5 - Google Patents

A selective inhibitor of protein arginine methyltransferase 5

Info

Publication number
IL285536A
IL285536A IL285536A IL28553621A IL285536A IL 285536 A IL285536 A IL 285536A IL 285536 A IL285536 A IL 285536A IL 28553621 A IL28553621 A IL 28553621A IL 285536 A IL285536 A IL 285536A
Authority
IL
Israel
Prior art keywords
prmt5
selective inhibitor
protein arginine
arginine methyltransferase
methyltransferase
Prior art date
Application number
IL285536A
Other languages
English (en)
Hebrew (he)
Original Assignee
Prelude Therapeutics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Prelude Therapeutics Inc filed Critical Prelude Therapeutics Inc
Publication of IL285536A publication Critical patent/IL285536A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/14—Pyrrolo-pyrimidine radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/13—Crystalline forms, e.g. polymorphs

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)
IL285536A 2019-02-13 2021-08-11 A selective inhibitor of protein arginine methyltransferase 5 IL285536A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201962805175P 2019-02-13 2019-02-13
US201962805726P 2019-02-14 2019-02-14
PCT/US2020/018185 WO2020168125A1 (en) 2019-02-13 2020-02-13 Selective inhibitor of protein arginine methyltransferase 5 (prmt5)

Publications (1)

Publication Number Publication Date
IL285536A true IL285536A (en) 2021-09-30

Family

ID=69845552

Family Applications (1)

Application Number Title Priority Date Filing Date
IL285536A IL285536A (en) 2019-02-13 2021-08-11 A selective inhibitor of protein arginine methyltransferase 5

Country Status (12)

Country Link
US (1) US20220160713A1 (cg-RX-API-DMAC10.html)
EP (1) EP3924360A1 (cg-RX-API-DMAC10.html)
JP (1) JP2022521491A (cg-RX-API-DMAC10.html)
KR (1) KR20210129051A (cg-RX-API-DMAC10.html)
CN (1) CN113811539A (cg-RX-API-DMAC10.html)
AU (1) AU2020223058A1 (cg-RX-API-DMAC10.html)
BR (1) BR112021015796A2 (cg-RX-API-DMAC10.html)
CA (1) CA3129612A1 (cg-RX-API-DMAC10.html)
IL (1) IL285536A (cg-RX-API-DMAC10.html)
MX (1) MX2021009796A (cg-RX-API-DMAC10.html)
WO (1) WO2020168125A1 (cg-RX-API-DMAC10.html)
ZA (1) ZA202105887B (cg-RX-API-DMAC10.html)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11077101B1 (en) 2018-07-18 2021-08-03 Tango Therapeutics, Inc. Compounds and methods of use
US12403137B2 (en) 2019-10-28 2025-09-02 Tango Therapeutics, Inc. Compounds and methods of use
CN116568677B (zh) 2020-07-31 2026-07-28 探戈医药股份有限公司 可用于治疗mtap缺乏和/或mta累积癌症的哌啶-1-基-n-吡啶-3-基-2-氧代乙酰胺衍生物
US20220251088A1 (en) * 2020-12-10 2022-08-11 Prelude Therapeutics, Incorporated Processes for Making PRMT5 Inhibitors

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3657744A (en) 1970-05-08 1972-04-25 Univ Minnesota Method for fixing prosthetic implants in a living body
US4733665C2 (en) 1985-11-07 2002-01-29 Expandable Grafts Partnership Expandable intraluminal graft and method and apparatus for implanting an expandable intraluminal graft
US5023252A (en) 1985-12-04 1991-06-11 Conrex Pharmaceutical Corporation Transdermal and trans-membrane delivery of drugs
US5040548A (en) 1989-06-01 1991-08-20 Yock Paul G Angioplasty mehtod
US5350395A (en) 1986-04-15 1994-09-27 Yock Paul G Angioplasty apparatus facilitating rapid exchanges
US5061273A (en) 1989-06-01 1991-10-29 Yock Paul G Angioplasty apparatus facilitating rapid exchanges
US4748982A (en) 1987-01-06 1988-06-07 Advanced Cardiovascular Systems, Inc. Reinforced balloon dilatation catheter with slitted exchange sleeve and method
US4992445A (en) 1987-06-12 1991-02-12 American Cyanamid Co. Transdermal delivery of pharmaceuticals
US5001139A (en) 1987-06-12 1991-03-19 American Cyanamid Company Enchancers for the transdermal flux of nivadipine
CA1322628C (en) 1988-10-04 1993-10-05 Richard A. Schatz Expandable intraluminal graft
US6344053B1 (en) 1993-12-22 2002-02-05 Medtronic Ave, Inc. Endovascular support device and method
US5292331A (en) 1989-08-24 1994-03-08 Applied Vascular Engineering, Inc. Endovascular support device
US5674278A (en) 1989-08-24 1997-10-07 Arterial Vascular Engineering, Inc. Endovascular support device
WO2015200680A2 (en) * 2014-06-25 2015-12-30 Epizyme, Inc. Prmt5 inhibitors and uses thereof
WO2016044576A1 (en) * 2014-09-17 2016-03-24 Epizyme, Inc. Salts, co-crystals, amorphous forms, and crystalline forms of an arginine methyltransferase inhibitor
EA031895B1 (ru) * 2015-02-24 2019-03-29 Пфайзер Инк. Замещенные нуклеозидные производные, полезные в качестве агентов против рака
MA41828A (fr) * 2015-03-27 2018-01-30 Pharmacyclics Llc Co-cristaux d'un inhibiteur de la tyrosine kinase de bruton
AR104326A1 (es) * 2015-05-04 2017-07-12 Lilly Co Eli Compuestos nucleósidos 5-sustituidos
TWI730980B (zh) * 2015-08-26 2021-06-21 比利時商健生藥品公司 使用作為prmt5抑制劑之新穎經6-6雙環芳香環取代之核苷類似物
MA49840A (fr) * 2017-08-09 2020-06-17 Prelude Therapeutics Inc Inhibiteurs sélectifs de la protéine arginine méthyltransférase 5 (prmt5)
WO2020033285A1 (en) * 2018-08-07 2020-02-13 Merck Sharp & Dohme Corp. Prmt5 inhibitors

Also Published As

Publication number Publication date
KR20210129051A (ko) 2021-10-27
ZA202105887B (en) 2024-12-18
AU2020223058A1 (en) 2021-09-09
BR112021015796A2 (pt) 2021-10-13
CA3129612A1 (en) 2020-08-20
JP2022521491A (ja) 2022-04-08
CN113811539A (zh) 2021-12-17
US20220160713A1 (en) 2022-05-26
WO2020168125A1 (en) 2020-08-20
EP3924360A1 (en) 2021-12-22
MX2021009796A (es) 2021-09-08

Similar Documents

Publication Publication Date Title
IL277263A (en) Selective inhibitors of protein arginine methyltransferase 5 (PRMT5)
IL272519B (en) Selective inhibitors of protein arginine methyltransferase 5 (prmt5)
EP3755317A4 (en) COMPOUNDS DEGRADING/DESTRUCTING PROTEIN ARGININE METHYLTRANSFERASE 5 (PRMT5) AND METHODS OF USE
IL288401A (en) prmt5 inhibitors
EP3952874A4 (en) SELECTIVE INHIBITORS OF PROTEIN ARGININE METHYLTRANSFERASE 5
IL286373B2 (en) Protein tyrosine phosphate inhibitor compounds and uses thereof
ZA202207450B (en) Kras mutant protein inhibitors
ZA202203770B (en) Pharmaceutical combination of prmt5 inhibitors
EP3946352A4 (en) SELECTIVE INHIBITORS OF PROTEIN ARGININE METHYLTRANSFERASE 5
IL280719A (en) Transglutaminase 2 (tg2) inhibitors
IL281720B2 (en) HMGB1 protein derivatives for biofilm removal
IL289778A (en) enzyme inhibitors
EP3341112A4 (en) METHOD AND COMPOSITIONS FOR PROTEIN CLEANING AND ENZYME REACTION
IL291417A (en) Selective inhibitors of protein arginine methyltransferase 5 (prmt5)
ZA202205799B (en) Substituted nucleoside analogs as prmt5 inhibitors
IL291284A (en) Systems and methods for expression of proteins
EP4076460A4 (en) PRMT5 INHIBITORS
IL291382A (en) 2-amino-s6-substituted thiopurine compounds as inhibitors of the enpp1 protein
HK40064833A (en) Selective inhibitor of protein arginine methyltransferase 5 (prmt5)
HK40078171A (en) Selective inhibitors of protein arginine methyltransferase 5 (prmt5)
EP3833667A4 (en) PRMT5 INHIBITORS
GB202111043D0 (en) Protein interaction inhibitors
GB202110970D0 (en) Protein interaction inhibitors
HK40044106A (en) Ethanediamine-heterocycle derivatives as inhibitors of protein arginine methyltransferases
HK40076766A (en) Mta-cooperative prmt5 inhibitors